| dc.contributor.author | Mitema, ES | |
| dc.contributor.author | Kocan, AA | |
| dc.contributor.author | Mukolwe, SW | |
| dc.contributor.author | Sangiah, S | |
| dc.contributor.author | Sherban, D | |
| dc.date.accessioned | 2013-06-25T12:58:11Z | |
| dc.date.available | 2013-06-25T12:58:11Z | |
| dc.date.issued | 1991-01 | |
| dc.identifier.citation | Vet Parasitol. 1991 Jan;38(1):49-53. | en |
| dc.identifier.uri | http://www.sciencedirect.com/science/article/pii/030440179190007I | |
| dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/39771 | |
| dc.description.abstract | Buparvaquone, a naphthoquinone with known efficacy against Theileria parva parva in cattle, was tested for activity against Theileria cervi piroplasms in both an in vitro culture system and in vivo in experimentally infected white-tailed deer. The in vitro data showed a significant decrease in the incorporation of 3H-hypoxanthine by infected red blood cells treated with buparvaquone when compared to that seen with imidocarb and chloroquine treatment. In both intact and splenectomized deer treated with buparvaquone (2.5 mg kg-1) a gradual decrease in piroplasm parasitaemia was observed following treatment. However, in the splenectomized deer, parasitaemia levels returned to near pretreatment values after approximately 2 weeks. | en |
| dc.language.iso | en | en |
| dc.publisher | University of Nairobi. | en |
| dc.title | Activity of buparvaquone against Theileria cervi in white-tailed deer. | en |
| dc.type | Article | en |
| local.publisher | Department of Public Health, Pharmacology and Toxicology | en |
